Skip to NavigationSkip to content

News

Researchers, based in the US, have conducted a large-scale collection of publicly available data and found that significant differences can be...
An ex-Director of Compliance for an Indiana-based Pharmakon has been found guilty of introducing adulterated drugs into the market and obstructing...
A clinical trial is to be launched to test AstraZeneca’s experimental drug, AZD1775, for the treatment of head and neck cancer in the UK.
Experts have developed a new form of therapy for patients living with schizophrenia, by allowing those individuals to speak to a generated ‘avatar’...
In good news for coffee drinkers, drinking three to four cups of coffee was found to lower the risk of certain cancers, diabetes-risk, liver disease...
The European Commission has granted Tesaro’s Zejula (niraparib) marketing approval in Europe, it has emerged.
There is a general push in the UK to find new digital means of reducing the workload on doctors and on GPs, as the NHS faces increased strain due to...
With the appointment of Kåre Schultz, the company hopes that it can take some hard decisions to turn around the company – one of the first steps...
Philp Hammond, the chancellor of exchequer, announced that the NHS would receive an additional commitment of £2.8 billion of resource funding, with £...
For every completed survey, £5 will be donated to charity. We invite you to participate in this short industry-wide survey which seeks to...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches